Business Latest News 

Can AstraZeneca Thrive on Its Own? Big Test Looms

The drug maker hopes the results of a trial for Mystic, a lung-cancer treatment, will prove it was right to fend off a 2014 takeover offer and commit to developing immunotherapy medicines. The Wall Street Journal:

Related posts

Leave a Comment

%d bloggers like this: